Showing results (611-620 of 1,053) with videos related to

Sort By:
Pageof 106
Plant Physiology|April 3, 2012
Histidine kinase activity of the ethylene receptor ETR1 facilitates the ethylene response in ArabidopsisBrenda P Hall, Samina N Shakeel, Madiha Amir, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Structure determination of an intercalating ruthenium dipyridophenazine complex which kinks DNA by semiintercalation of a tetraazaphenanthrene ligandJames P Hall, Kyra O'Sullivan, Abeer Naseer, et al.
The Journal of Pathology|January 30, 1999
Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expressionA P Hall, J Irvine, K Blyth, et al.
Biochimica Et Biophysica Acta|May 30, 1998
Variations in the subunit content and catalytic activity of the cytochrome c oxidase complex from different tissues and different cardiac compartmentsC Vijayasarathy, I Biunno, N Lenka, et al.
Clinical Biochemistry|August 17, 2010
LC-MS/MS progress in newborn screeningD C Lehotay, P Hall, J Lepage, et al.
Hepatology (Baltimore, Md.)|January 1, 1984
Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridizationC J Burrell, E J Gowans, R Rowland, et al.
Circulation|March 4, 1997
Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapyR Albiero, P Hall, A Itoh, et al.
Radiation Research|December 1, 1996
Thyroid nodularity after diagnostic administration of iodine-131P Hall, C J Fürst, A Mattsson, et al.
Circulation|January 15, 1996
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantationP Hall, S Nakamura, L Maiello, et al.
British Journal of Cancer|February 1, 1991
High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II studyS A Gomm, N Thatcher, A Cuthbert, et al.
Pageof 106